These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 8045123)
1. Drug treatment options for multidrug-resistant tuberculosis. Patel K Conn Med; 1994 Apr; 58(4):227-30. PubMed ID: 8045123 [No Abstract] [Full Text] [Related]
2. Reporting on multidrug-resistant tuberculosis: a proposed definition for the treatment outcome 'failed'. Chiang CY; Caminero JA; Enarson DA Int J Tuberc Lung Dis; 2009 May; 13(5):548-50. PubMed ID: 19383184 [No Abstract] [Full Text] [Related]
3. [Spread of multidrug resistance of Mycobacterium and its impact on the efficiency of treatment in patients with tuberculosis in the penitentiaries of the Arkhangelsk Region]. Mar'iandyshev AO; Nizovtseva NI; Glomozda PG; Panasik VP; Duginova TN; Kuznetsov AA Probl Tuberk Bolezn Legk; 2005; (5):19-21. PubMed ID: 15988972 [TBL] [Abstract][Full Text] [Related]
4. Multidrug-resistant tuberculosis. Carlos L; da Silva C; Müller L; da Silva C N Engl J Med; 1996 Jan; 334(4):267-8; author reply 268-9. PubMed ID: 8532009 [No Abstract] [Full Text] [Related]
5. Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TB. Chan ED; Strand MJ; Iseman MD Clin Infect Dis; 2009 Mar; 48(5):e50-2. PubMed ID: 19191632 [TBL] [Abstract][Full Text] [Related]
8. Multi drug resistant tuberculosis. Dey AB; Nagarkar K Trop Gastroenterol; 1995; 16(2):92-100. PubMed ID: 8644369 [TBL] [Abstract][Full Text] [Related]
9. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results. Migliori GB; Lange C; Girardi E; Centis R; Besozzi G; Kliiman K; Ortmann J; Matteelli A; Spanevello A; Cirillo DM; Clin Infect Dis; 2008 Mar; 46(6):958-9. PubMed ID: 18288911 [No Abstract] [Full Text] [Related]
10. Drug-resistant mycobacterium tuberculosis; some data from Sweden, Estonia and Ethiopia. Hoffner SE Scand J Infect Dis Suppl; 1995; 98():17-8. PubMed ID: 8867172 [TBL] [Abstract][Full Text] [Related]
12. Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis. Yew WW; Chang KC; Chau CH J Antimicrob Chemother; 2009 Nov; 64(5):1119; author reply 1119-20. PubMed ID: 19666903 [No Abstract] [Full Text] [Related]
13. The impact of drug resistance on the global tuberculosis epidemic. Schluger NW Int J Tuberc Lung Dis; 2000 Feb; 4(2 Suppl 1):S71-5. PubMed ID: 10688153 [No Abstract] [Full Text] [Related]
15. [Ways of overcoming drug resistance in patients with pulmonary tuberculosis]. Grishin MN; Svistov VV; Krivoshein IuS Probl Tuberk; 2002; (3):16-8. PubMed ID: 12066525 [TBL] [Abstract][Full Text] [Related]
16. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis--authors' response. Koh WJ; Shim TS J Antimicrob Chemother; 2009 Nov; 64(5):1119-20. PubMed ID: 19744986 [No Abstract] [Full Text] [Related]
17. Multidrug-resistant tuberculosis: response to treatment. Saenghirunvattana S; Charoenpan P; Vathesatogkit P; Kiatboonsri S; Aeursudkij B J Med Assoc Thai; 1996 Sep; 79(9):601-3. PubMed ID: 8996991 [TBL] [Abstract][Full Text] [Related]
18. Multidrug resistant tuberculosis in Auckland 1988-95. Cameron RJ; Harrison AC N Z Med J; 1997 Apr; 110(1041):119-22. PubMed ID: 9140412 [TBL] [Abstract][Full Text] [Related]